Investigation Overview
October 6, 2016 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of EndoChoice Holdings Inc (NYSE:GI), was announced concerning whether the takeover of EndoChoice Holdings Inc. by Boston Scientific for $8.00 per share is unfair to NYSE:GI stockholders. The investigation by a law firm concerns whether certain officers and directors of Endo...
You must register (for free) or login to view the entire investigation.